Blood markers may predict chemo success in colorectal cancer
NCT ID NCT02872779
First seen Feb 01, 2026 · Last updated May 08, 2026 · Updated 21 times
Summary
This study tested whether early changes in blood markers (like CEA and tumor DNA) can predict if chemotherapy is working for people with metastatic colorectal cancer. 74 patients were followed for 3 months. The goal was to see if these blood tests could replace or supplement standard scans to guide treatment decisions earlier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rouen University Hospital
Rouen, France
Conditions
Explore the condition pages connected to this study.